Please Wait.....
Report
Japan Veterinary Healthcare - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-09-01 I 102 Pages I Mordor Intelligence
Japan Veterinary Healthcare Market Analysis
The Japan veterinary healthcare market size stood at USD 2.68 billion in 2025 and is projected to reach USD 3.71 billion by 2030, advancing at a 6.67% CAGR. This expansion reflects the country's rapid shift from a livestock-centric model to a companion-animal focus, with pets now outnumbering children under fifteen. Growth catalysts include the steady rollout of digital diagnostics, wider pet-insurance adoption, and supportive government biosecurity budgets. The Japan veterinary healthcare market also benefits from rising demand for premium therapeutics such as monoclonal antibodies and cannabidiol supplements, together with new workflow software that shortens diagnosis-to-treatment cycles. At the same time, declining domestic meat consumption curbs farm-animal revenue, prompting companies to diversify toward high-margin companion-animal services while leveraging the same distribution channels for both segments.
Japan Veterinary Healthcare Market Trends and Insights
Rising Companion Animal Expenditure
Lifetime ownership costs climbed to JPY 2.446 million (USD 16,300) for dogs and JPY 1.499 million (USD 10,000) for cats in 2025, underscoring household readiness to fund complex oncology, cardiology, and orthopedic care. Heightened spending links to strong pet-insurance coverage, with Anicom Insurance supporting more than 7,000 partner clinics nationwide. Owners of pets under one year accept treatment bills of USD 800-1,200 per ingestion incident, reaffirming healthcare as a core component of pet well-being.
Government Vaccination Campaigns for Livestock Biosecurity
The Ministry of Agriculture, Forestry and Fisheries maintains a 6.2 million-dose avian-influenza reserve and mandates 24-hour reporting of suspect cases, a legacy of the 2010 foot-and-mouth crisis in which 289,000 animals were culled. Regular surveillance and movement controls ensure reliable demand for vaccines and rapid tests across 4.56 million cattle, 9.61 million pigs, and 294 million chickens.
Escalating Veterinary Service Costs
Clinic fees have risen 60% faster than consumer inflation since 2005, driven by workforce shortages and imported-drug price hikes. Nearly 48.4% of owners name cost as the main deterrent to vet visits, with 13.7% foregoing annual check-ups entirely. Rural closures amplify access gaps, prompting clinics to adopt installment payments and teleconsults to sustain care quality while moderating price growth.
Other drivers and restraints analyzed in the detailed report include:
Technological Advancements in Veterinary Diagnostics / Expansion of Pet-Insurance Analytics Ecosystems / Counterfeit Pharmaceutical Distribution /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Therapeutics accounted for 61.43% of the Japan veterinary healthcare market share in 2024, anchored by vaccine mandates and the popularity of parasiticides. Monoclonal antibody products for osteoarthritis and parenteral analgesics register double-digit clinic uptake, reflecting owner readiness to pay for human-grade care. Companion-animal vaccines post high adherence, while livestock biologics rely on government procurement that smooths annual demand.
Diagnostics, the fastest-growing category at a 7.12% CAGR, benefits from in-house PCR, immunoassay, and digital imaging platforms that deliver immediate results and raise practice revenue. As value-based preventive care gains traction, diagnostic vendors emphasize return-on-investment metrics such as reduced follow-up visits and higher client satisfaction. Market consolidation emerges as distributors bundle equipment leasing, reagent supply, and cloud analytics, shortening time to profit for clinics.
Dogs and cats captured 43.67% of the Japan veterinary healthcare market size in 2024. Specialized oncology, orthopedic, and cardiology procedures expand, and subscription wellness packages that bundle check-ups with nutritional advice secure recurring income at clinics. Insurers reimburse advanced imaging such as CT and MRI, which lifts adoption rates in urban hospitals.
Poultry is forecast to grow at a 6.53% CAGR, propelled by mandatory vaccination and PCR monitoring in intensive layer and broiler farms across Kyushu. Larger producers integrate sensor-enabled barns and employ analytics to predict disease outbreaks, sustaining demand for biologics and realtime diagnostic kits. Swine and cattle segments see mild expansion as domestic meat consumption stabilizes; however premium Wagyu breeders still invest heavily in reproductive and genomic services.
The Japan Veterinary Healthcare Market Report is Segmented by Product (Therapeutics and Diagnostics), Animal Type (Dogs & Cats, Horses, and More), Route of Administration (Oral, Parenteral, and More), End User (Veterinary Hospitals & Clinics, Reference Laboratories, Point-Of-Care/In-House Testing Settings, Academic & Research Institutes). The Market Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Elanco / Boehringer Ingelheim / Kyoritsu Seiyaku Corporation / FUJIFILM / Merck & Co., Inc. (MSD Animal Health) / Nihon Nohyaku Co., Ltd. / Nippon Zenyaku Kogyo Co., Ltd. / Nisseiken / Sumitomo Pharma Co., Ltd. / Virbac / Zoetis / IDEXX / Ceva Sante Animale SA / Anicom / Vetoquinol / Canon / Sumika Enviro-Science Co., Ltd. / Chugai Pharmaceutical / Nihon Pet Food Co., Ltd. / Kyodo Milk Industry Co., Ltd. /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Companion Animal Expenditure
4.2.2 Government Vaccination Campaigns for Livestock Biosecurity
4.2.3 Technological Advancements in Veterinary Diagnostics
4.2.4 Expansion of Pet Insurance Data Analytics Ecosystems
4.2.5 Emerging Demand For Alternative Therapies such as CBD Nutraceuticals
4.3 Market Restraints
4.3.1 Escalating Veterinary Service Costs
4.3.2 Counterfeit Pharmaceutical Distribution
4.3.3 Shrinking Domestic Livestock Population Due to Dietary Shifts
4.3.4 Regulatory Approval Delays for Novel Therapeutics
4.4 Regulatory Landscape
4.5 Porter's Five Forces Analysis
4.5.1 Threat Of New Entrants
4.5.2 Bargaining Power Of Buyers/Consumers
4.5.3 Bargaining Power Of Suppliers
4.5.4 Threat Of Substitute Products
4.5.5 Intensity Of Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Product
5.1.1 Therapeutics
5.1.1.1 Vaccines
5.1.1.2 Parasiticides
5.1.1.3 Anti-Infectives
5.1.1.4 Medical Feed Additives
5.1.1.5 Other Therapeutics
5.1.2 Diagnostics
5.1.2.1 Immunodiagnostic Tests
5.1.2.2 Molecular Diagnostics
5.1.2.3 Diagnostic Imaging
5.1.2.4 Clinical Chemistry
5.1.2.5 Other Diagnostics
5.2 By Animal Type
5.2.1 Dogs & Cats
5.2.2 Horses
5.2.3 Ruminants
5.2.4 Swine
5.2.5 Poultry
5.2.6 Other Animal Types
5.3 By Route Of Administration
5.3.1 Oral
5.3.2 Parenteral
5.3.3 Topical
5.3.4 Other Route of Administrations
5.4 By End User
5.4.1 Veterinary Hospitals & Clinics
5.4.2 Reference Laboratories
5.4.3 Point-Of-Care / In-House Testing Settings
5.4.4 Academic & Research Institutes
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
6.3.1 Elanco Animal Health Incorporated
6.3.2 Boehringer Ingelheim GmbH
6.3.3 Kyoritsu Seiyaku Corporation
6.3.4 FUJIFILM Holdings Corporation
6.3.5 Merck & Co., Inc. (MSD Animal Health)
6.3.6 Nihon Nohyaku Co., Ltd.
6.3.7 Nippon Zenyaku Kogyo Co., Ltd.
6.3.8 Nisseiken Co., Ltd.
6.3.9 Sumitomo Pharma Co., Ltd.
6.3.10 Virbac SA
6.3.11 Zoetis Inc.
6.3.12 IDEXX Laboratories Inc.
6.3.13 Ceva Sante Animale SA
6.3.14 Anicom Holdings Inc.
6.3.15 Vetoquinol SA
6.3.16 Canon Medical Systems Corp.
6.3.17 Sumika Enviro-Science Co., Ltd.
6.3.18 Chugai Pharmaceutical Co., Ltd.
6.3.19 Nihon Pet Food Co., Ltd.
6.3.20 Kyodo Milk Industry Co., Ltd.
7 Market Opportunities & Future Outlook
7.1 White-Space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security